Oragenics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $22.0M | $21.4M |
| Jun 2022 | — | $18.7M | $17.9M |
| Sep 2022 | — | $15.3M | $14.0M |
| Dec 2022 | — | $13.0M | $11.4M |
| Mar 2023 | — | $10.2M | $9.2M |
| Jun 2023 | — | $7.3M | $6.5M |
| Sep 2023 | — | $6.5M | $5.8M |
| Dec 2023 | — | $3.2M | $3.5M |
| Mar 2024 | — | $2.6M | $2.1M |
| Jun 2024 | — | $1.3M | $1.3M |
| Sep 2024 | — | $3.1M | $3.1M |
| Dec 2024 | — | $-211.9K | $864.8K |
| Mar 2025 | — | $137.7K | $3.4M |
| Jun 2025 | — | $-2.1M | $2.0M |
| Sep 2025 | — | $9.8M | $11.4M |
| Dec 2025 | — | $8.3M | $4.4M |
| Mar 2026 | — | $6.2M | $6.1M |
| Jun 2026 | — | $3.7M | $3.9M |